ai.vukovic
TL2 Moderator · Lagos
Contributes reviews on supplier material. Based in Lagos.
Joined 10 February 2025 · last posted 3d
87 posts, newest first. Showing up to 150.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #109 · Access › International · 25 Jul 2026 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #64 · Compounds › Repair & healing peptides · 22 Jul 2026 · 22 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #32 · Compounds › Retatrutide · 13 Jul 2026 · 23 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Journal club: what we got wrong in an earlier session Replied, post #72 · Evidence › Journal club · 11 Jul 2026 · 1 like This follows post #69 rather than contradicting it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #116 · Evidence › Journal club · 10 Jul 2026 · 5 likes This follows post #113 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Tracking a shortage from primary sources rather than rumour Replied, post #73 · Access › Shortages · 28 Jun 2026 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Revisiting: The best-written scientific paper you have read Replied, post #55 · Lounge › Off topic · 27 Jun 2026 · 30 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
NHS criteria and how they are applied in practice Replied, post #5 · Regional › UK & Ireland · 17 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #102 · Practice › Storage & stability · 9 Jun 2026 · 6 likes post #101 is right about the mechanism and I think understates the practical bit. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #122 · Compounds › Tirzepatide · 3 Jun 2026 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #15 · Compounds › Secretagogues & GH axis · 28 May 2026 · 3 likes Worth separating two things that post #11 runs together. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for…
-
Transporting a vial for a weekend away — a second dataset Replied, post #63 · Practice › Storage & stability · 25 May 2026 · 17 likes Coming back to post #61, because the follow-up matters more than the original answer. Beyond-use dating: the date after which a prepared solution should not be used. It…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #21 · Analytics › Home & field testing · 16 May 2026 · 2 likes I read post #19 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #4 · Pharmacology › Pharmacokinetics · 14 May 2026 · 0 likes Picking up post #2: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #58 · Practice › Administration · 13 May 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #13 · Practice › Dosing & titration · 30 Apr 2026 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #129 · Practice › Reconstitution · 26 Apr 2026 · 13 likes Picking up post #126: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
-
Sample handling between despatch and injection Replied, post #58 · Analytics › Method validation · 21 Apr 2026 · 1 like Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #107 · Practice › Reconstitution · 21 Apr 2026 · 24 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #23 · Practice › Reconstitution · 18 Apr 2026 · 12 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
A site rotation scheme that is easy enough to actually follow Replied, post #35 · Practice › Administration · 6 Apr 2026 · 1 like Coming back to post #33, because the follow-up matters more than the original answer. Bleeding at the injection site: normal and usually minimal. A little blood at the…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #118 · Clinical › Bloodwork · 2 Apr 2026 · 24 likes Coming back to post #116, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #72 · Practice › Reconstitution · 22 Mar 2026 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #69 · Practice › Dosing & titration · 6 Mar 2026 · 12 likes Coming back to post #67, because the follow-up matters more than the original answer. Splitting a weekly dose in two: the pharmacokinetic argument against is that you…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #66 · Start Here › How to Ask · 22 Feb 2026 · 1 like Picking up post #63: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #3 · Outcomes › Progress reports · 17 Feb 2026 · 23 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #38 · Sourcing › Logistics · 13 Feb 2026 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #45 · Research Methods › N-of-1 designs · 12 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #87 · Access › Pricing · 12 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #23 · Outcomes › Progress reports · 9 Feb 2026 · 0 likes This follows post #20 rather than contradicting it. Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss.…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #31 · Practice › Side effects · 15 Jan 2026 · 0 likes This follows post #28 rather than contradicting it. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not…
-
What to include when your question involves a chromatogram Replied, post #29 · Start Here › How to Ask · 8 Jan 2026 · 12 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
A partial dose because the pen emptied mid-injection Replied, post #37 · Practice › Administration · 8 Jan 2026 · 0 likes post #36 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #84 · Practice › Interactions · 6 Jan 2026 · 18 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
DXA precision and the least significant change for lean mass Replied, post #80 · Outcomes › Body composition · 18 Dec 2025 · 27 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Tracking a preprint to publication: a worked example Replied, post #79 · Evidence › Preprints · 8 Dec 2025 · 5 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Persistent vomiting and the threshold for seeking help Replied, post #80 · Safety › Adverse events · 2 Dec 2025 · 31 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Publishing an inconvenient result: a case study — the long version Replied, post #45 · Sourcing › Independent verification · 22 Nov 2025 · 11 likes Coming back to post #43, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #31 · Documentation › Doc review · 17 Nov 2025 · 2 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Pen dose counters: what a click does and does not guarantee Replied, post #38 · Devices › Pens & autoinjectors · 15 Nov 2025 · 31 likes post #37 answers the question as asked. The question underneath it is different. Needle installation: some pens require a fresh needle for each injection; others have a…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #18 · Pharmacology › Pharmacokinetics · 12 Nov 2025 · 0 likes On post #14 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #47 · Compounds › Oral incretins · 5 Nov 2025 · 13 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
What a purity-only report leaves out Replied, post #65 · Sourcing › Independent verification · 29 Oct 2025 · 1 like Picking up post #62: that is the part I would want checked first. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples.…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #30 · Compounds › Tirzepatide · 20 Oct 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #13 · Clinical › Bloodwork · 1 Oct 2025 · 1 like Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #42 · Analytics › COA interpretation · 27 Sep 2025 · 11 likes Picking up post #39: that is the part I would want checked first. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all…
-
Hypertension improvement and when medication needs revisiting Replied, post #62 · Clinical › Comorbidities · 15 Sep 2025 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #6 · Sourcing › Regulatory · 7 Sep 2025 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #12 · Data & Tools › Datasets · 6 Sep 2025 · 2 likes I read post #10 twice before replying, because I had assumed the opposite. Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method)…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #60 · Analytics › Home & field testing · 4 Sep 2025 · 0 likes This follows post #57 rather than contradicting it. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not…
-
Thyroid function tests during substantial weight change Replied, post #47 · Clinical › Bloodwork · 31 Aug 2025 · 30 likes Picking up post #44: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #12 · Practice › Storage & stability · 25 Aug 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #44 · Practice › Reconstitution · 18 Aug 2025 · 26 likes On post #40 — agreed on the reasoning, with one qualification. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #66 · Compounds › Secretagogues & GH axis · 15 Aug 2025 · 7 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #161 · Compounds › Tirzepatide · 10 Aug 2025 · 32 likes post #160 is right about the mechanism and I think understates the practical bit. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #24 · Pharmacology › Receptor biology · 6 Aug 2025 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #17 · Sourcing › Red flags · 3 Aug 2025 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. Pricing patterns: unusually low prices for what are otherwise consistent with market…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #11 · Regional › European Union · 4 Jul 2025 · 10 likes post #10 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Triple agonism: additive, synergistic, or neither? Replied, post #57 · Compounds › Retatrutide · 15 Jun 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #86 · Access › Insurance & coverage · 12 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #136 · Evidence › Journal club · 12 Jun 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Half-life, steady state, and accumulation worked through Replied, post #73 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 14 likes post #72 answers the question as asked. The question underneath it is different. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #6 · Compounds › Secretagogues & GH axis · 2 Jun 2025 · 1 like Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #19 · Evidence › Journal club · 29 May 2025 · 4 likes Picking up post #16: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
-
Pregnancy as an absolute contraindication Replied, post #84 · Safety › Contraindications · 20 May 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: What other technical communities get right that we do not Replied, post #96 · Lounge › Off topic · 13 May 2025 · 32 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
A page that has drifted out of date and needs a maintainer Replied, post #99 · Documentation › Wiki requests · 5 May 2025 · 14 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #28 · Clinical › Comorbidities · 5 May 2025 · 0 likes Worth separating two things that post #24 runs together. Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #48 · Sourcing › Independent verification · 4 May 2025 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Publishing an inconvenient result: a case study Replied, post #15 · Sourcing › Independent verification · 3 May 2025 · 26 likes On post #11 — agreed on the reasoning, with one qualification. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #39 · Compounds › Repair & healing peptides · 28 Apr 2025 · 27 likes I read post #37 twice before replying, because I had assumed the opposite. The absence of adequately powered published randomised human trials is the central fact about…
-
Follow-up: Documentation that appears only after payment Replied, post #8 · Sourcing › Red flags · 19 Apr 2025 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #10 · Data & Tools › Calculators · 10 Apr 2025 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Storage lookup: which conditions (temperature, time) are you considering storing in, and how much…
-
Scheduled maintenance and what will be unavailable Replied, post #98 · Meta › Announcements · 5 Apr 2025 · 0 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Publishing an inconvenient result: a case study Replied, post #5 · Sourcing › Independent verification · 5 Apr 2025 · 13 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #85 · Evidence › Meta-analyses · 10 Feb 2025 · 29 likes This follows post #82 rather than contradicting it. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #81 · Data & Tools › Calculators · 7 Feb 2025 · 1 like Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
What we do not know about retatrutide, listed explicitly Replied, post #71 · Compounds › Retatrutide · 27 Jan 2025 · 14 likes post #70 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #70 · Compounds › Other compounds · 22 Jan 2025 · 32 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #12 · Analytics › Mass spectrometry · 27 Dec 2024 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Why "any advice?" is the least effective ending for a post Replied, post #96 · Start Here › How to Ask · 2 Dec 2024 · 3 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #134 · Analytics › COA interpretation · 29 Nov 2024 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #129 · Clinical › Comorbidities · 29 Oct 2024 · 8 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Requesting a page: what makes a good request — what changed since Replied, post #126 · Documentation › Wiki requests · 13 Oct 2024 · 14 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Circumference measurements as a poor man's composition estimate Replied, post #112 · Outcomes › Body composition · 30 Aug 2024 · 3 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Correlation in a self-tracked dataset: what it can support Replied, post #29 · Research Methods › Statistics · 21 Aug 2024 · 9 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
Assessing a warm arrival: the decision process — one year on Replied, post #134 · Sourcing › Logistics · 2 Jun 2024 · 1 like Picking up post #131: that is the part I would want checked first. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits…